Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed8
Recruiting2

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT07318038Not ApplicableCompleted
The Use of Rhythmic Light Therapy in Mild Cognitive Impairment
Mild Cognitive Impairment
PrincipalinvestigatorStart date: 2025-12-08
NCT07095270Not ApplicableCompleted
Evaluation of Circadian OS Technology on Melatonin Suppression
Circadian Disruption
PrincipalinvestigatorStart date: 2025-07-07
NCT06595030Not ApplicableCompleted
Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3
Alzheimer's DiseaseMild Cognitive Impairment
PrincipalinvestigatorStart date: 2024-12-03
NCT05016219Not ApplicableRecruiting
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
Mild Cognitive Impairment
PrincipalinvestigatorStart date: 2023-08-22
NCT05596994Not ApplicableCompleted
7T MRI for Light Therapy in Patients With Mild Cognitive Impairment and Mild AD
Alzheimer's DiseaseMild Cognitive Impairment
PrincipalinvestigatorStart date: 2023-02-28
NCT05837819Not ApplicableCompleted
Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2
Alzheimer's DiseaseSleep Disturbance
PrincipalinvestigatorStart date: 2023-02-14
NCT05737732Not ApplicableRecruiting
The Ambient Light Multiple Myeloma Study
Multiple Myeloma
PrincipalinvestigatorStart date: 2023-02-13
NCT05015478Not ApplicableCompleted
Rhythmic Light Therapy for Alzheimer's Disease Patients
Mild Cognitive Impairment
PrincipalinvestigatorStart date: 2022-01-10
NCT04073628Not ApplicableCompleted
The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment
Alzheimer's DiseaseMild Cognitive Impairment
PrincipalinvestigatorStart date: 2021-06-14
NCT03777722Not ApplicableCompleted
Light and the Effect on Metabolic Syndrome and Alzheimer's Disease
Alzheimer DiseaseDiabetes Mellitus, Type 2
PrincipalinvestigatorStart date: 2018-11-19

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Priti Balchandani, PhD

Icahn School of Medicine at Mount Sinai

Related
1 trials

Shared therapeutic areas:

Alzheimer DiseaseMild Cognitive Impairment

Worked with same sponsors:

Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)
Collaborated on 1 trial
Similarity Score24%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Alzheimer DiseaseMild Cognitive ImpairmentMultiple Myeloma
Similarity Score15%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Alzheimer DiseaseDiabetes Mellitus, Type 2
Similarity Score10%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Alzheimer DiseaseMild Cognitive Impairment
Similarity Score10%

Paolo Bonato, PhD

Spaulding Rehabilitation Hospital

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score5%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score5%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score5%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score5%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2
Similarity Score5%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT07318038Not ApplicablePrincipalInvestigator

The Use of Rhythmic Light Therapy in Mild Cognitive Impairment

Mild Cognitive Impairment
Completed
NCT07095270Not ApplicablePrincipalInvestigator

Evaluation of Circadian OS Technology on Melatonin Suppression

Circadian Disruption
Completed
NCT06595030Not ApplicablePrincipalInvestigator

Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3

Alzheimer's DiseaseMild Cognitive Impairment
Completed
NCT05016219Not ApplicablePrincipalInvestigator

Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients

Mild Cognitive Impairment
Recruiting
NCT05596994Not ApplicablePrincipalInvestigator

7T MRI for Light Therapy in Patients With Mild Cognitive Impairment and Mild AD

Alzheimer's DiseaseMild Cognitive Impairment
Completed
NCT05837819Not ApplicablePrincipalInvestigator

Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2

Alzheimer's DiseaseSleep Disturbance
Completed
NCT05737732Not ApplicablePrincipalInvestigator

The Ambient Light Multiple Myeloma Study

Multiple Myeloma
Recruiting
NCT05015478Not ApplicablePrincipalInvestigator

Rhythmic Light Therapy for Alzheimer's Disease Patients

Mild Cognitive Impairment
Completed
NCT04073628Not ApplicablePrincipalInvestigator

The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment

Alzheimer's DiseaseMild Cognitive Impairment
Completed
NCT03777722Not ApplicablePrincipalInvestigator

Light and the Effect on Metabolic Syndrome and Alzheimer's Disease

Alzheimer DiseaseDiabetes Mellitus, Type 2
Completed

All 10 trials loaded